Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Jan 13, 2022 1:04pm
136 Views
Post# 34313410

RE:RE:Just The Facts

RE:RE:Just The Facts

theNorm wrote: Financial reports lag by at least 2 months BUT good companys like VPT include "Subsequent Events" in the SEDAR MD&A.

The last financing was an upsized bought deal at 52 cents with 70 cent warrants that have an acceleration clause.  The only other warrants were part of that as comm so @1million at .52
There are just over 7.5 million options to mgmt.  With the current low float of 154 million and this little overhang of options and wts this is a very, very attractive stock at this ridiculous low valuation.

Covid has made it hard to sell and install, we can still expect an update on the last 4 sales 2021.
Some of the money from fall is being used to start Veteranary initiative for pets where VPT should be able to move swiftly with human approvals already in place so I expect news on that front soon.

VPT has proven it's a simple process to train technicians on VMS 3.0 and achieve accurate results.  VMS 3.0 has been adapted in Canada, the U.S., Europe and China and has good reviews.  People don't have to wait for 4.0, they can buy 3.0 and simple do a software upgrade when 4.0 is ready.

Admitedly George is doing a poor job of marketing to shareholders BUT hospitals are buying.  GEHC is taking longer than expected to promote and launch VMS but it's promised soon, Apr at the very latest.

Venture companys often don't show profitability for years.  This one will suddenly rocket in value once GEHC Edison program launches and their sales force finally goes to work.

Do not think you can continue to bash here without repurcussions.  I will be reporting every lie and every deception going forward.  Yuse brokers ain't bashing my picks no more without grief.
If you have any information about fraudulent investment schemes, money laundering or any other criminality, you can contact your local police, the Ontario RCMP at 1-800-387-0020, or report anonymously through Crime Stoppers at 1-800-222-8477 (TIPS), at any time. 


Your post does not address the facts I have presented, instead diverts into a discussion about the recent financing and then tangentially suggests the float size will lead to price changes, and speculate that a program that hasnt been launched will cause the stock will"rocket in value". 

If the sales reporting is delayed because of a 2 month lag in reporting as you say, why did the financials prior to that also fail to be reported?

Is it all COVID?

What were the total sales PRIOR to COVID?

These are facts and fact based questions.

I dont know who your threats are directed at-but they make little sense in relation to my fact based posts and questions.

In contrast, your forward looking statements, and unsupported price predictions are suspect.
 

<< Previous
Bullboard Posts
Next >>